A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone To Improve Persistence With Endocrine Therapy In Young Women With Stage I-III Breast Cancer (ASPEN)

This study is being done to answer the following question: Will monitoring side effects in between clinic visits help women keep taking their hormone therapy medicine as prescribed for early-stage breast cancer? This study is being done to find out if this approach is better or worse than the usual approach for helping women take their hormone therapy medicine. The usual approach is the follow-up care most people get after they are diagnosed with breast cancer and start hormone therapy.

Are you Eligible? (Inclusion Criteria)

• Are you 18 years of age or older, but not yet menopausal? Have you been diagnosed with Stage I, II, or III hormone receptor positive breast cancer? Are you willing to answer questions about the symptoms you experience in between clinic visits?